Ray Sumita sold $266K of CUE
Ray Sumita (Chief Legal Compliance Officer) sold 8,829 shares of Cue Biopharma, Inc. (CUE) at an average of $30.09 ($29.37–$31.13, $0.27M total) across 3 trades on 2026-08-13.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed sale of 8,829 shares for about $265.6k, with post-transaction holdings of 118,545 shares.
Market read
Traders may monitor for follow-on insider activity, but the filing alone does not provide a fundamental catalyst.
What to watch
Insider sales are often planned for liquidity and do not necessarily reflect negative expectations; the filing lacks any accompanying narrative or company event.
Background
This is an SEC Form 4 insider transaction disclosure for Cue Biopharma, Inc., reported by Chief Legal Compliance Officer Ray Sumita.
Ticker impact
Cue Biopharma disclosed a Form 4 showing officer Ray Sumita sold $265,627.93 of CUE shares in open-market trades on 2026-08-13.
Likely limited near-term impact; treat as low-signal unless paired with other disclosures.
The article provides only the transaction details (size, dates, prices) and notes no 10b5-1 plan, but it does not include any new operational, regulatory, or financial catalyst.
Market effects
No sector-wide implication is provided; this is company-specific insider trading disclosure.
None indicated.
None indicated.
Counterpoint
Absence of a 10b5-1 plan could be interpreted as discretionary selling, which some traders may read as caution.
Key entities
- issuerCue Biopharma, Inc.
US-listed biotech issuer subject of the Form 4 insider sale disclosure.
- insiderRay Sumita
Chief Legal Compliance Officer who sold shares in open-market transactions.
